thymalfasin
1 clinical trial
1 abstract
1 indication
Indication
Locally Advanced Rectal CancerAbstract
A precise thymalfasin-regulated PRaG regimen for advanced refractory solid tumors: An open-label, prospective, multicenter clinical study (PRaG 5.0 study).Org: The Second Affiliated Hospital of Soochow University, Department of Radiotherapy & Oncology,
Clinical trial
Efficacy and Safety of Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin in pMMR/MSS Locally Advanced Middle and Low Rectal Cancer: An Open, Multi-center, Prospective, Single-arm Phase II Clinical StudyStatus: Not yet recruiting, Estimated PCD: 2024-07-01